First manuscript publication! Thank you Mary Kimmel for encouraging this important work.

🎉Excited to share our review on the genomic landscape of prostate cancer, what we know so far about its relationship to race, and how we project its future! Grateful for the rigorous, thoughtful, and superb editorial process of Nature Reviews Urology nature.com/articles/s4158…

Just under a month until #AUA23! Thrilled to present our latest work from University Hospitals Urology Institute #ShoagLab in Chicago! 🌆 Eager to exchange ideas and learn from colleagues and experts in the field. Ilon C. Weinstein, MD Jonathan Evan Shoag 🇮🇱🇺🇸

Excited to visit Chicago for #AUA23. Let’s talk Prostate!

Trade off with MRI-targeted biopsies: less upgrading but more downgrading at RP. Coming soon to European Urology Oncology! #AUA23

MRI-targeted prostate biopsy results in less upgrading, more downgrading at radical prostatectomy. #urology #urologist #pcsm #prostatecancer Jonathan Evan Shoag 🇮🇱🇺🇸 Ilon C. Weinstein, MD University Hospitals Urology Institute Read more: urologytimes.com/view/mri-targe…

HoLEP has lower readmission and comparable retreatment rates to TURP, but utilization in the U.S. remains low. University Hospitals Urology Institute Jonathan Evan Shoag 🇮🇱🇺🇸 Michael Zell MD Irina Jaeger, MD Urology Gold Journal sciencedirect.com/science/articl…

Featured today by MSK Library: Adoption & Outcomes of Holmium #LaserEnucleation of the #Prostate in the United States Ilon C. Weinstein, MD Camilo Arenas-Gallo Bashir Al Hussein Christopher Gaffney Michael Zell MD Irina Jaeger, MD Lee Ponsky Jonathan Evan Shoag 🇮🇱🇺🇸 Urology Gold Journal dx.doi.org/10.1016/j.urol…

So excited to be joining this awesome team!!